![logo](/logos/LONN.SW.webp)
Lonza Group AG
SIX:LONN.SW
536.2 (CHF) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Lonza Group AG |
Symbool | LONN.SW |
Munteenheid | CHF |
Prijs | 536.2 |
Beurswaarde | 39,106,081,563 |
Dividendpercentage | 0% |
52-weken bereik | 308.6 - 589.4 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Albert M. Baehny |
Website | https://www.lonza.com |
An error occurred while fetching data.
Over Lonza Group AG
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CHF)
Cijfers zijn in miljoenen (CHF)